GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dishman Carbogen Amics Ltd (NSE:DCAL) » Definitions » Revenue

Dishman Carbogen Amics (NSE:DCAL) Revenue : ₹25,465 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Dishman Carbogen Amics Revenue?

Dishman Carbogen Amics's revenue for the three months ended in Sep. 2024 was ₹7,890 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹25,465 Mil. Dishman Carbogen Amics's Revenue per Share for the three months ended in Sep. 2024 was ₹50.31. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹162.34.

During the past 12 months, the average Revenue per Share Growth Rate of Dishman Carbogen Amics was 3.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 10.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 6.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Dishman Carbogen Amics's highest 3-Year average Revenue per Share Growth Rate was 56.40% per year. The lowest was 1.30% per year. And the median was 7.65% per year.


Dishman Carbogen Amics Revenue Historical Data

The historical data trend for Dishman Carbogen Amics's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dishman Carbogen Amics Revenue Chart

Dishman Carbogen Amics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20,436.00 19,120.30 21,406.80 23,150.50 25,436.20

Dishman Carbogen Amics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,865.90 6,510.90 5,825.60 5,237.80 7,890.40

Competitive Comparison of Dishman Carbogen Amics's Revenue

For the Biotechnology subindustry, Dishman Carbogen Amics's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dishman Carbogen Amics's Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Revenue distribution charts can be found below:

* The bar in red indicates where Dishman Carbogen Amics's Revenue falls into.



Dishman Carbogen Amics Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹25,465 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dishman Carbogen Amics  (NSE:DCAL) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Dishman Carbogen Amics Revenue Related Terms

Thank you for viewing the detailed overview of Dishman Carbogen Amics's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dishman Carbogen Amics Business Description

Traded in Other Exchanges
Address
Iscon-Bopal Road, Dishman Corporate House, Ambli, Ahmedabad, GJ, IND, 380 058
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.

Dishman Carbogen Amics Headlines

No Headlines